Shaping the Future of Market Access and Reimbursement

CI’s Forum provides a critical platform for stakeholders—government, pharmaceutical manufacturers, patients, and payers—to engage in meaningful discussions on market access, drug price regulation and drug reimbursement. Seize the opportunity to explore innovative approaches to ensure patient access to the right drug at the right time.

As in years prior, the 2026 program will ensure that you start the new year with a clear view of Canada’s pharmaceutical landscape. This must-attend event for market access professionals offers timely analysis of the latest policies impacting the pharmaceutical sector and strategic insights on how to work with public and private payers to expedite patient access.

Benefits to Attending

Icon

Build a market access and drug pricing plan based on insights from CDA, INESSS, patients, and industry leaders.

Icon

Prepare for PMPRB’s impending draft guidelines for drug pricing review.

Icon

Align drugs submissions with payer priorities.

Icon

Develop an understanding of how to use AI and digital tools to support market access.

Icon

Collaborate with the life sciences community on strategies to improve the collection and use of RWE for drug access decisions.


Who You Will Meet

Practitioners at every level with experience in:

  • Pricing
  • Reimbursement
  • Market access
  • Patient access
  • Government and regulatory affairs
  • Health economics
  • Research and development
  • Policy and compliance
  • Pharmacy services
  • Marketing
  • National trade
  • Formularies
  • Business development
  • Sales

From brand generic and manufacturing companies involved in:

  • Product development
  • Public drug programs
  • Pharmaceutical benefits
  • Pharmaceutical strategy
  • Drug submissions
  • Formulary management
  • Policy and economic analysis
  • Provider services and relations
  • Pharmacy

And representatives from:

  • Associations
  • Patient Advocacy Groups
“Great overview, gave me a different perspective. Got me thinking differently.”
—Team Lead, Pricing and Contracts, GSK
“I liked the quality of the speakers.”
—Manager, Market Access and HTA, BMS
“Overall excellent topics and speakers. Truly enjoyed the selection of speakers and the panels.”
—Manager, Pricing and Contracts, Astellas

Questions?

Email us at [email protected]

Get in Touch

Ready to Register?

Secure your space now.

Register Now